Ketan Patel, MD
Geriatric Medicine · Milford, OHNPI 1699721050
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $387 of the $474 with a category attached, or 81.7%. It is spread thinly across 15 manufacturers, the largest accounting for just 18.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $210 and has fallen 91.8% since, to $17 in 2024.
Across 19 payments — averaging $24.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$88
- Sanofi-aventis U.S. LLC$87
- Vifor Pharma, Inc.$47
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$41
- Bioxcel Therapeutics, Inc.$38
- Mylan Specialty L.p.$27
- plus $145 from 9 others
What the payments were for
- Food & beverage$38782%
- Education$8718%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 1 | $88 |
| Sanofi-aventis U.S. LLC | 1 | $87 |
| Vifor Pharma, Inc. | 3 | $47 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $41 |
| Bioxcel Therapeutics, Inc. | 2 | $38 |
| Mylan Specialty L.p. | 1 | $27 |
| Novartis | 1 | $23 |
| Melinta Therapeutics, LLC | 1 | $20 |
| Astellas Pharma US Inc | 1 | $18 |
| Smith+Nephew | 1 | $17 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $16 |
| AstraZeneca | 1 | $14 |
| AbbVie | 1 | $12 |
| Pfizer | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
How this compares
$474 in reported general payments places this provider in the 70th percentile of 146 geriatric medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 29 | $15,797 |
| CefuroximeCefuroxime Axetil | 33 | $559 |
| Pantoprazole Sodium | 40 | $465 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 30 | $451 |
| Atorvastatin Calcium | 29 | $232 |
| Glimepiride | 12 | $193 |
| Amlodipine Besylate | 33 | $163 |
| Tamsulosin Hcl | 13 | $161 |
| Metoprolol Succinate | 11 | $140 |
| Hydralazine Hcl | 17 | $122 |
| Metoprolol Tartrate | 20 | $120 |
| Prednisone | 34 | $119 |
| Carvedilol | 21 | $112 |
| Levofloxacin | 20 | $101 |
| Lisinopril | 21 | $98 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $12 | $15,79729 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 146 geriatric medicine providers in Ohio.
Other geriatric medicine in Milford
- Meenakshi PatelCenterville$644K
- Daniel CannoneWadsworth$423K
- Babak TousiCleveland$215K
- Brinder VijWest Chester$92K
- Sean CannoneCopley$74K
- Tai-Chi KwokWooster$26K
- James FidelholtzCincinnati$15K
- Rodney IsonCanal Fulton$10K
- Ronan FactoraCleveland$9K
- Gurjeet KahlonCenterville$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.